Sangon Biotech: difference between revisions
Diff·revision 9 → 10·21:46, 19 Mar 2025
Difference between revision 9 and revision 10 of Sangon Biotech. 11 lines changed; the page grew by 822 bytes.
| Revision 9 — 19:48, 1 Mar 2025 BlindSampleBrid (talk) expand §Independent testing record 5,945 bytes +643 | Revision 10 — 21:46, 19 Mar 2025 ColdChainCleo (talk) clarify that a registered business scope is a licensing fact, not a quality assurance 6,767 bytes +822 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = Sangon Biotech (Shanghai) Co., Ltd. | 2 | | name = Sangon Biotech (Shanghai) Co., Ltd. |
| + | 3 | | subtitle = Organisation | |
| 3 | | image = facility.svg | 4 | | image = facility.svg |
| 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | 5 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. |
| ⋮ | ⋮ | ||
| 11 | | Industry = Research-compound supply | 12 | | Industry = Research-compound supply |
| 12 | | Official site = [https://sangonbio.com/ Visit SGN at sangonbio.com] | 13 | | Official site = [https://sangonbio.com/ Visit SGN at sangonbio.com] |
| + | 14 | <!-- Products and documentation --> | |
| + | 15 | | Product scope = peptides, SARMs, injectable oils and raw materials | |
| + | 16 | | Catalogue size = 350+ listings (self-reported) | |
| + | 17 | | Documentation = Batch certificate of analysis reported with orders | |
| + | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | |
| 13 | }} | 19 | }} |
| 14 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 40 | | Oligonucleotides | Synthesis to order | Certificate, sequence confirmation | | 46 | | Oligonucleotides | Synthesis to order | Certificate, sequence confirmation | |
| 41 | | SARMs and raw materials | Bulk | Certificate, purity | | 47 | | SARMs and raw materials | Bulk | Certificate, purity | |
| + | 48 | ||
| + | 49 | The reagent and oligonucleotide lines place this organisation in a different category from most covered here. Its inclusion in this wiki's supplier articles reflects its peptide listings, not the whole of its business.{{r|selfpub}} | |
| + | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | Submitted reports on SGN peptide material to July 2026 are moderate in number. Reported [[Area percent purity|area percent]] figures have been high and consistent with accompanying certificates.{{r|reports}} | |
| 42 | 53 | ||
| 43 | == References == | 54 | == References == |